Tibsovo

(ivosidenib)
TIBSOVO 250 MG Oral Tablet

Dosage & administration

500 mg orally once daily with or without food until disease progression or unacceptable toxicity . Avoid a high-fat meal.

Most viewed Tibsovo resources

Enroll in Patient Savings Program

drug label

Tibsovo prescribing information

prior authorization

Tibsovo prior authorization resources

Most recent Tibsovo prior authorization forms

View By Payer
Verified: Feb 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Mar 02, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Mar 02, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Mar 02, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Mar 02, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Feb 27, 2024Arizona - Uniform Prior Authorization Form
Verified: Feb 27, 2024Colorado - Uniform Prior Authorization Form
Verified: Feb 27, 2024Hawaii - Uniform Prior Authorization Form
Verified: Feb 27, 2024Illinois - Uniform Prior Authorization Form
Verified: Feb 27, 2024Indiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Louisiana - Uniform Prior Authorization Form
Verified: Feb 27, 2024Michigan - Uniform Prior Authorization Form
Verified: Feb 27, 2024Minnesota - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Feb 27, 2024New Mexico - Uniform Prior Authorization Form
Verified: Feb 27, 2024Oregon - Uniform Prior Authorization Form
Verified: Feb 27, 2024Texas - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Appeal
Learn More

Benefits investigation

Servier One Enrollment Form
Learn More

pharmacy

Tibsovo preferred pharmacy

Pharmacy List

financial assistance

Tibsovo financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Servier One Enrollment Form
Bridge Program - Max 2 Month Supply
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Servier One Enrollment Form
Patient Assistance Program
Learn More

PubMed™ | Tibsovo

Tibsovo PubMed™ News

patient education

Tibsovo patient education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Other Patient Resources - Servier ONE for Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Acute Myeloid Leukemia (AML) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Cholangiocarcinoma (CCA) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Tibsovo FAQs

How is the dosage of Tibsovo?Tibsovo is available in 1 dosages, including 250 mg Tab
What does Tibsovo treat?Tibsovo treats Acute Myeloid Leukemia
What is Tibsovo made of?Tibsovo contains ivosidenib which is a Isocitrate Dehydrogenase 1 Inhibitor
How Is Tibsovo Administered?Tibsovo is administered as a Oral Pill
What Are The Tibsovo Mechanism Of Action?Tibsovo mechanism of action is Cytochrome P450 2C9 Inducers, Cytochrome P450 3A4 Inducers or Isocitrate Dehydrogenase 1 Inhibitors
FAQ Data Source